We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $43.4B
1-Year Est. Return 51.29%
This Fund
S&P 500
This Quarter Est. Return
+9.13%
1 Year Est. Return
+51.29%
3 Year Est. Return
+133.48%
5 Year Est. Return
+173.9%
10 Year Est. Return
+551.09%
AUM
$20.5B
AUM Growth
+$1.31B
Cap. Flow
-$64.5M
Cap. Flow %
-0.31%
Top 10 Hldgs %
30.13%
Holding
1,270
New
254
Increased
410
Reduced
389
Closed
206

Top Sells

Rank Stock Value
1
RY icon
Royal Bank of Canada
RY
+$115M
2
ENB icon
Enbridge
ENB
+$87.8M
3
PFE icon
Pfizer
PFE
+$80.4M
4
CNI icon
Canadian National Railway
CNI
+$78.6M
5
AAPL icon
Apple
AAPL
+$73.1M

Sector Composition

Rank Sector Weight
1 Financials 24.6%
2 Technology 17.8%
3 Industrials 12.95%
4 Communication Services 8.37%
5 Materials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STLD icon
826
Steel Dynamics
STLD
$37.3B
$428K ﹤0.01%
+6,889
New +$431K
VEON icon
827
VEON
VEON
$3.93B
$426K ﹤0.01%
9,956
+7,641
+330% +$373K
BSET icon
828
Bassett Furniture
BSET
$170M
$424K ﹤0.01%
25,313
-6,217
-20% -$108K
ACIC icon
829
American Coastal Insurance
ACIC
$461M
$421K ﹤0.01%
97,075
+62,072
+177% +$266K
TTC icon
830
Toro Company
TTC
$9.21B
$420K ﹤0.01%
+4,199
New +$418K
MELI icon
831
Mercado Libre
MELI
$92.7B
$419K ﹤0.01%
311
-1,201
-79% -$1.69M
ATEX icon
832
Anterix
ATEX
$1.79B
$418K ﹤0.01%
7,106
-2,540
-26% -$154K
PBH icon
833
Prestige Consumer Healthcare
PBH
$2.43B
$413K ﹤0.01%
+6,813
New +$404K
NXGN
834
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$413K ﹤0.01%
+23,233
New +$373K
ARGX icon
835
argenx
ARGX
$53.6B
$412K ﹤0.01%
1,176
-110
-9% -$33.5K
MIRM icon
836
Mirum Pharmaceuticals
MIRM
$6.02B
$409K ﹤0.01%
+25,618
New +$399K
NBN icon
837
Northeast Bank
NBN
$1.16B
$405K ﹤0.01%
11,330
+2,720
+32% +$94.4K
BWFG icon
838
Bankwell Financial Group
BWFG
$542M
$401K ﹤0.01%
12,224
+2,581
+27% +$79.7K
UMC icon
839
United Microelectronic
UMC
$48.6B
$401K ﹤0.01%
34,270
-735,845
-96% -$8.19M
TXT icon
840
Textron
TXT
$15.1B
$400K ﹤0.01%
5,185
+803
+18% +$59.6K
VYGR icon
841
Voyager Therapeutics
VYGR
$198M
$400K ﹤0.01%
147,534
+115,404
+359% +$394K
ASMB icon
842
Assembly Biosciences
ASMB
$594M
$397K ﹤0.01%
14,185
+1,150
+9% +$37.7K
MA icon
843
Mastercard
MA
$497B
$396K ﹤0.01%
1,101
-30,456
-97% -$10.5M
ATLO icon
844
AMES National
ATLO
$281M
$394K ﹤0.01%
16,096
+1,488
+10% +$36K
TDAY
845
USA Today Co
TDAY
$1B
$394K ﹤0.01%
74,002
-422,271
-85% -$2.36M
STR
846
DELISTED
Sitio Royalties
STR
$390K ﹤0.01%
20,003
+16,511
+473% +$352K
ALBO
847
DELISTED
Albireo Pharma Inc
ALBO
$390K ﹤0.01%
+16,757
New +$446K
BGSF icon
848
BGSF Inc
BGSF
$59.2M
$389K ﹤0.01%
27,140
+5,911
+28% +$80K
NTP
849
DELISTED
Nam Tai Property Inc.
NTP
$388K ﹤0.01%
38,478
-66,217
-63% -$1.32M
SYRS
850
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$387K ﹤0.01%
11,863
+1,532
+15% +$62K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2021 Portfolio in Review

As of Q4 2021, Connor, Clark & Lunn Investment Management (CC&L) held 1,270 positions worth $20.5B, up 6.8% from $19.2B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L)'s Q4 2021 filing shows 254 new, 410 increased, 389 reduced and 206 closed positions. Its largest new stake was Nuvei Corporation Subordinate Voting Shares: 879,610 shares worth $57.1M. The largest sale was Royal Bank of Canada, an estimated $115M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q4 2021 buy was Nuvei Corporation Subordinate Voting Shares: 879,610 shares worth $57.1M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Waste Connections in Q4 2021, an estimated $102M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q4 2021 reduction was Royal Bank of Canada, cutting an estimated $115M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q4 2021, selling an estimated $26.6M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 30% of its $20.5B portfolio in Q4 2021.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 254 new positions and closed 206 in Q4 2021.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 6.8% quarter-over-quarter to $20.5B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2021, filed 10 Feb 2022.